| ²é¿´: 442 | »Ø¸´: 2 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
yin198716гæ (ÕýʽдÊÖ)
|
[ÇóÖú]
µ¥¾äÇóÖú
|
|
| In summary, in recent years DLL4 has appeared as a significant regulator of tumor angiogenesis. Blockade of this ligand results in non-productive angiogenesis with an inhibitory effect on tumor growth. Nevertheless, the careful evaluation of adverse effects on physiology of normal organs in relation to therapeutic doses of DLL4 inhibitors will be critical for advancement of DLL4 blocking agents in clinical oncology. |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
324Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Èí¼þ¹¤³ÌÇóµ÷¼Á22Èí¹¤296·ÖÇóµ÷¼Á£¬½ÓÊÜ¿çµ÷
ÒѾÓÐ3È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ10È˻ظ´
278Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
»¯¹¤Ñ§Ë¶ 285Çóµ÷¼Á
ÒѾÓÐ26È˻ظ´
Ò»Ö¾Ô¸0703»¯Ñ§ÕÐ61×îÖÕÅÅÃû62»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
±¾¿Æ211£¬293·ÖÇëÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´

ÕŹúÓª2176
гæ (СÓÐÃûÆø)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 144.9
- Ìû×Ó: 57
- ÔÚÏß: 15.9Сʱ
- ³æºÅ: 2441457
- ×¢²á: 2013-04-29
- רҵ: ¹Ç¡¢¹Ø½Ú¡¢Èí×éÖ¯ËðÉËÓëÐÞ
3Â¥2013-09-23 23:00:35
xux730
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 86
- Ó¦Öú: 1719 (½²Ê¦)
- ½ð±Ò: 10740.4
- É¢½ð: 50
- ºì»¨: 43
- Ìû×Ó: 2947
- ÔÚÏß: 336.5Сʱ
- ³æºÅ: 1374299
- ×¢²á: 2011-08-20
- רҵ: ϸ°ûÖÜÆÚÓëµ÷¿Ø
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
yin198716: ½ð±Ò+5, ·ÒëEPI+1 2013-09-23 23:44:16
yin198716: ½ð±Ò+5, ·ÒëEPI+1 2013-09-23 23:44:16
| ×ÜÖ®£¬ÔÚ×î½ü¼¸ÄêÖÐDLL4Ã÷ÏÔ³ÉΪÖ×ÁöѪ¹ÜÉú³ÉµÄÒ»¸öÏÔÖøµ÷½ÚÒò×Ó¡£×è¶Ï¸ÃÅäÌåµ¼Ö¶ÔÖ×ÁöÉú³¤¾ßÓÐÒÖÖÆÐ§¹ûµÄÎÞЧѪ¹ÜÉú³É¡£È»¶ø£¬×ÐϸÆÀ¹ÀÖÎÁƼÁÁ¿µÄDLL4ÒÖÖÆ¼Á¶ÔÕý³£Æ÷¹ÙÉúÀíÉϵIJ»Á¼Ó°Ï콫ÊÇDLL4×è¶Ï¼ÁÔÚÁÙ´²Ö×ÁöѧȡµÃ½øÕ¹µÄ¹Ø¼ü¡£ |
2Â¥2013-09-23 22:04:15














»Ø¸´´ËÂ¥